Delivery Order SPE2DR25D1109-SPE2DR26FFL3P
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,202.14 to AmerisourceBergen Drug Corp for 250 mg vials of Ryanodex, a pharmaceutical product used in anesthesia and critical care settings. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was issued on January 12, 2026, with an ultimate completion date of February 3, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $3,108.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 mg vials of Ryanodex, a pharmaceutical product used in acute care settings. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 10, 2025. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the company's established infrastructure as a major pharmaceutical...
- The Defense Logistics Agency awarded a $9,606.42 delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Ryanodex 250 mg vials, with performance completion scheduled for February 5, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The work will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $6,421.76 firm fixed-price delivery order for 250 mg vials of Ryanodex, a muscle relaxant used primarily in anesthesia and critical care settings. This non-competitive delivery order, issued on June 20, 2025, with an ultimate completion date of July 14, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $9,632.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ryanodex 250 mg vials. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ryanodex is a rapid-sequence intubation agent used in emergency...
- The Defense Logistics Agency awarded a $11,207.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials, with an ultimate completion date of February 13, 2026. This is a non-set-aside contract competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which...
- The Defense Logistics Agency awarded a delivery order valued at $9,606.42 to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials, with performance to be completed by December 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as...
- The U.S. Defense Medical Supply Chain awarded a $52,979.52 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price delivery order is set to conclude on August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,108.56 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ryanodex 250 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, executed through an open competitive process with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,210.88 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ryanodex 250 mg vials, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under the vendor's...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFL3PDelivery Order
The Defense Logistics Agency awarded a $1,601.07 firm fixed-price delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 23, 2026, for 250 mg vials of Ryanodex, a rapid-sequence intubation agent used in emergency medical procedures. This is a competitively awarded, non-set-aside contract with performance through February 13, 2026, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and established federal vendor that supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of competitively awarded delivery orders demonstrates its capability to efficiently fulfill government pharmaceutical procurement requirements at varying volumes, from low-value transactions to substantial orders. This delivery order exemplifies the company's continued role in supporting military medical readiness through the provision of critical pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/22/26 |